Zota Health Care Ltd.

View in App
486.25 -5.35 ▼-1.1%

18 April 2024, 03:59:08 PM
Volume: 8,532

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.zotahealthcare.com
Market Cap 1,289.87 Cr.
Enterprise Value(EV) 1,288.05 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -3.79 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.01 Trailing Twelve Months Ending 2023-12
Book Value / Share 43.10 Trailing Twelve Months Ending 2023-12
Price to Book Value 11.28 Calculated using Price: 486.25
Dividend Yield 0.21 Period Ending 2023-03
No. of Shares Subscribed 2.65 Cr. 26,526,827 Shares
FaceValue 10
About Zota Health Care Ltd.
Zota Health Care manufactures and markets pharmaceutical formulations, nutraceutical, and ayurvedic medicines in India and internationally. They mainly market generic, patented and OTC pharmaceutical products. Products are marketed in the form of tablets, capsules, ointment, oral liquids, injectable etc as per customers need.

Zota Health Care Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Zota Health Care Ltd. Performance

View details >>
1 Day
-1.09%
1 Week
-2.35%
1 Month
+2.30%
3 Month
-0.28%
6 Month
+18.57%
1 Year
+77.37%
2 Year
+44.87%
5 Year
+147.54%
10 Year

Zota Health Care Ltd. Fundamental Ratios

View details >>
5 years 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 8.05 3.98 -0.31 11.43 -6.79
Return on Capital Employed (%) 11.45 5.71 -0.38 16.36 -2.5
Return on Assets (%) 6.19 3.08 -0.24 7.94 -3.9

Zota Health Care Ltd. Balance Sheet

View details >>
Particulars 6 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 69 69 66 90 80 102
Non Curr. Liab. 1 1 1 13 36 50
Curr. Liab. 20 19 18 36 41 30
Minority Int.
Equity & Liab. 90 88 85 139 157 183
Non Curr. Assets 27 30 24 62 73 96
Curr. Assets 62 59 61 77 84 87
Misc. Exp. not W/O
Total Assets 90 88 85 139 157 183

Zota Health Care Ltd. Profit and Loss

View details >>
Particulars 6 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 86 95 107 131 140 168
Other Income 2 2 1 2 3 1
Total Income 87 97 108 133 143 168
Total Expenditure -78 -91 -106 -117 -133 -158
PBIDT 9 6 2 16 9 11
Interest 0 0 0 0 -3 -4
Depreciation -1 -2 -3 -4 -12 -17
Taxation -2 -1 0 -4 -1 0
Exceptional Items 1 1 1
PAT 6 3 0 9 -6 -10
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 6 3 0 9 -6 -10
Adjusted EPS 2 1 0 4 -2 -4

Zota Health Care Ltd. Cash Flow

View details >>
Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -3 6 -1 13 -2
Cash Fr. Inv. 9 -4 4 -27 15
Cash Fr. Finan. -6 -3 -2 14 -14
Net Change -1 -1 1 1 -1
Cash & Cash Eqvt 2 1 1 2 1

Zota Health Care Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 68.09 68.11 68.12 68.12 68.12 68.12 68.12 66.16 66.15
Public 31.91 31.89 31.88 31.88 31.88 31.88 31.88 33.84 33.85
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.01 0.01 0.01 0.27 0.27 0.27 0.27 0.28 0.28
No. of Shareholders (in Lacs)

Zota Health Care Ltd. Announcements

View details >>
Thu, 18 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Zota Health Care LImited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Thu, 18 Apr 2024
Disclosure under SEBI Takeover Regulations
Himanshu Muktilal Zota has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Mon, 08 Apr 2024
Disclosure under SEBI Takeover Regulations
Zota Health Care LImitedￂﾠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaￂﾠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ￂﾠ

Zota Health Care Ltd. Technical Scans

View details >>
Thu, 18 Apr 2024
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Year High Increase in 1 Year
High Increase in 5 Years High Increase in 5 Years
Close Crossing 100 SMA From Above Close Crossing 100 SMA From Above

Zota Health Care Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,015.10 1,523.80 -0.9%
Cipla Ltd. 108,808.58 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. 99,408.67 5,959.10 -1.5%
Divi's Laboratories Ltd. 98,683.96 3,717.35 -1.3%
Mankind Pharma Ltd. 96,037.07 2,397.40 +5.0%
Zydus Lifesciences Ltd. 94,213.69 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. 87,250.69 6,107.00 -3.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.87 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-12 29.34 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.01 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-12 71.36 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-12 55.61 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.68 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 110.54 6,107.00 -3.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.83 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-12 4.20 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.57 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-12 10.81 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.00 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 12.92 6,107.00 -3.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,107.00 -3.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,107.00 -3.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,107.00 -3.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,107.00 -3.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,523.80 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,352.95 -1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,959.10 -1.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,717.35 -1.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,397.40 +5.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 934.50 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,107.00 -3.6%

Zota Health Care Ltd. FAQ's

What is Zota Health Care share price?
Can I buy Zota Health Care shares now?
What is the Dividend Yield of Zota Health Care?
What is the Market Cap of Zota Health Care?
What are the key metrics to analyse Zota Health Care?
What is the 52 Week High and Low of Zota Health Care?
What is the trend of Zota Health Care share price?